Aptamer-Drug Engager

Jinling Chen1,2, Hongli Chi1,2, Chao Wang3

  • 1School of Life Sciences, Faculty of Medicine, Tianjin University, Tianjin 300072, China.

概括

这项研究引入了可编程的aptamer药物联体,可激活癌症免疫治疗的先天性和适应性免疫. 在临床前模型中,这些新兴药物表现出强大的抗瘤作用和持久的全身疗效.

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K